CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer.

ABSTRACT:

SUBMITTER: Sun S 

PROVIDER: S-EPMC6424781 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature